Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di... 11/04/2024 Approximately 10,000 new cases of Parkinson's are detected each year in Spain, with a total figure exceeding 150,000... AseBio
Biotechnology lays the groundwork for the present and future of healthcare and drives the ... 07/04/2024 Healthcare Drug discovery Rare diseases Personalized medicine Advanced therapies Antibiotic resistance Climate change Agrifood Animal health The health pipeline of AseBio includes 130 molecules for 150 indications being investigated by 40 national companies... AseBio
Biotechnology lays the groundwork for the present and future of healthcare and drives the ... 07/04/2024 AseBio's health pipeline includes 130 molecules for 150 indications being researched by 40 national companies, with... AseBio
The Spanish AI Healthcare Landscape 04/04/2024 Healthcare Access to innovation Rare diseases Personalized medicine While not yet a global player, Artificial Intelligence (AI) is increasingly being integrated into the healthcare... Partners - OWKIN
Almirall signs licensing agreement with Eloxx Pharmaceuticals and enters the field of rare... 25/03/2024 Healthcare Access to innovation Rare diseases Personalized medicine Advanced therapies The Spanish pharmaceutical company has obtained global rights to develop and commercialize the drug ZKN-013. Partners - Almirall
Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the ... 20/03/2024 Healthcare Personalized medicine Financing Ysios Capital participates in the financing round for the capital increase of the US company Engrail Therapeutics. Partners - Ysios Capital Partners
Biotechnology to reduce the risk of kidney transplant failure and adverse events related t... 14/03/2024 Healthcare Innovative drugs Personalized medicine On the occasion of World Kidney Day, we interviewed Isabel Portero, founder and CEO of Biophope, a biotechnology company... AseBio - Biohope
Why and how to involve rare disease patients in the evaluation process of a new health tec... 27/02/2024 Healthcare Rare diseases Innovative drugs Personalized medicine Advanced therapies Alira Health experts explain in an interview the importance of involving patients with rare diseases in the evaluation... Partners
ORYZON reports financial results and corporate update for quarter ended December 31, 2023 27/02/2024 Healthcare Innovative drugs Personalized medicine Advanced therapies Oryzon Genomics, a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with... Partners - Oryzon Genomics
Biotechnology is revolutionizing the present and future of the fight against cancer 02/02/2024 Immunotherapy, gene therapy, the study of mRNA and its potential application in vaccines, nanotechnology, liquid biopsy... AseBio
